Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
41.27
+1.41 (3.54%)
At close: Aug 13, 2025, 4:00 PM
41.18
-0.09 (-0.22%)
After-hours: Aug 13, 2025, 7:59 PM EDT
Viking Therapeutics Stock Forecast
Stock Price Forecast
According to 13 professional analysts, the 12-month price target for Viking Therapeutics stock ranges from a low of $30 to a high of $138. The average analyst price target of $86.92 forecasts a 110.61% increase in the stock price over the next year.
Price Target: $86.92 (+110.61%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Viking Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 4 | 4 | 4 | 5 | 5 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Strong Buy Maintains $125 → $122 | Strong Buy | Maintains | $125 → $122 | +195.61% | Jul 24, 2025 |
| Citigroup | Citigroup | Hold Maintains $31 → $38 | Hold | Maintains | $31 → $38 | -7.92% | Jul 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $102 | Strong Buy | Reiterates | $102 | +147.15% | Jun 25, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $104 | Buy | Initiates | $104 | +152.00% | Apr 28, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $95 → $75 | Strong Buy | Reiterates | $95 → $75 | +81.73% | Apr 28, 2025 |
Financial Forecast
Revenue This Year
1.50M
Revenue Next Year
6.58M
from 1.50M
Increased by 338.60%
EPS This Year
-1.93
from -1.01
EPS Next Year
-2.62
from -1.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.3M | 97.9M | 292.9M | ||
| Avg | 1.5M | 6.6M | 21.7M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 6,424.0% | 4,351.3% | ||
| Avg | - | 338.6% | 230.4% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.55 | -1.86 | -1.80 | ||
| Avg | -1.93 | -2.62 | -3.04 | ||
| Low | -2.52 | -3.93 | -4.19 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.